North America Blockchain in Healthcare Market Outlook, 2030

The North American blockchain in healthcare market is experiencing robust growth fueled by the imperative for secure and efficient data management within the healthcare sector. Blockchain technology, with its decentralized and immutable ledger, offers a compelling solution to address data security vulnerabilities, interoperability challenges, and the need for greater transparency. This surge in adoption spans various applications, including streamlining clinical data exchange and ensuring interoperability between disparate systems, enhancing supply chain management to combat counterfeiting and ensure drug integrity, optimizing claims adjudication and billing processes for efficiency and accuracy, and improving the integrity and security of clinical trials. Key market drivers include escalating concerns about data breaches and the vulnerability of sensitive patient information, the pressing need for improved interoperability to facilitate seamless data sharing between healthcare stakeholders, growing demand for transparency and traceability, particularly in the pharmaceutical supply chain, and increasing government support through initiatives and funding programs. However, challenges persist, including the high implementation costs associated with blockchain solutions, the current lack of standardized protocols and frameworks which can hinder interoperability, regulatory uncertainty surrounding the use of blockchain in healthcare, and a shortage of skilled professionals capable of developing and deploying these complex systems. Despite these hurdles, significant opportunities exist, such as the growing adoption of cloud-based blockchain platforms offering cost-effective scalability, the emergence of innovative applications like patient identity management, drug discovery, and personalized medicine, and the increasing number of collaborations and partnerships driving innovation. Key players in this market, including IBM, Oracle, Microsoft, Accenture, Change Healthcare, Patientory, Guardtime, BurstIQ, and Medicalchain, are actively developing and deploying blockchain solutions. The market outlook predicts substantial growth in the coming years, driven by the persistent need for secure data management, ongoing government support, and the exploration of new blockchain applications, ultimately holding the potential to revolutionize healthcare and improve patient outcomes despite existing challenges.

North America blockchain in healthcare market is expected to grow by 67.7% annually in the forecast period and reach $20.46 billion by 2030 driven by the healthcare data security, development of blockchain consortiums, government initiatives, increasing instances of data breaches and surging adoption of blockchain technology in healthcare and pharma industries. The North American blockchain in healthcare market is currently experiencing a dynamic period of evolution, driven by a confluence of influential trends, powerful market forces, and a growing ecosystem of trade programs. A prominent trend is the increasing emphasis on data security and privacy, as healthcare organizations grapple with the rising tide of cyberattacks and data breaches. Blockchain's inherent security features, including encryption and decentralized ledger technology, offer a robust defense against these threats, making it an attractive solution for safeguarding sensitive patient information. Another key trend is the push for interoperability within the healthcare ecosystem. Traditionally, healthcare data has been siloed across various systems, hindering efficient information sharing and care coordination. Blockchain has the potential to facilitate secure and seamless data exchange between providers, payers, and patients, leading to improved patient outcomes and streamlined processes. Furthermore, the market is witnessing a growing focus on supply chain transparency and traceability, particularly in the pharmaceutical industry. Blockchain can be used to track medications from manufacturing to distribution, helping to combat counterfeit drugs and ensure the integrity of the supply chain. This is particularly critical in North America, where drug counterfeiting poses a significant threat to public health. These trends are being fueled by several key market drivers. The rising cost of healthcare is a major concern, and blockchain solutions offer the potential to streamline administrative processes, reduce fraud, and improve efficiency, ultimately leading to cost savings. The increasing regulatory scrutiny of data privacy and security is also driving the adoption of blockchain, as healthcare organizations seek to comply with regulations like HIPAA and GDPR. Additionally, the growing demand for patient-centric care is pushing healthcare providers to adopt technologies that empower patients with greater control over their health information. Blockchain can enable patients to securely access and share their medical records, fostering greater engagement in their own care.
The North American blockchain in healthcare market can be segmented by offering into platforms, solutions, and services. Platforms provide the foundational infrastructure for developing and deploying blockchain applications, offering features like smart contract development, data management, and network security. These platforms cater to organizations seeking to build customized blockchain solutions tailored to their specific needs. Solutions, on the other hand, are pre-built applications designed to address specific healthcare challenges, such as supply chain management, clinical data exchange, or claims processing. These solutions offer a faster and more cost-effective way for healthcare organizations to leverage blockchain technology without the need for extensive in-house development. Services encompass a range of professional offerings, including consulting, implementation, integration, and maintenance of blockchain solutions. These services are crucial for organizations lacking the necessary expertise to effectively deploy and manage blockchain technology. The market is witnessing a growing demand for all three offerings, with platforms enabling innovation, solutions providing readily available functionalities, and services facilitating seamless adoption. The choice of offering depends on the specific needs and resources of the healthcare organization. For instance, a large hospital with in-house development capabilities might opt for a platform to build custom applications, while a smaller clinic might prefer a pre-built solution for a specific use case. The services segment is crucial for driving market adoption, as it provides the necessary support and expertise for healthcare organizations to navigate the complexities of blockchain technology. Furthermore, the convergence of these offerings is becoming increasingly common, with vendors offering integrated solutions that combine platforms, applications, and services into a comprehensive package. This trend is expected to further accelerate market growth by simplifying the adoption process and providing end-to-end solutions for healthcare organizations. As the market matures, specialized platforms, solutions, and services are emerging to cater to specific niche areas within the healthcare industry, such as pharmaceutical supply chain management or patient identity management. This specialization is expected to further drive market segmentation and innovation.
The North American blockchain in healthcare market's "Type" segment comprises public, private, and hybrid blockchains, each offering distinct characteristics and suitability for various healthcare applications. Public blockchains, being permissionless and decentralized, prioritize transparency and security, making them potentially useful for tracking pharmaceuticals, managing patient consent, and storing anonymized research data, though privacy concerns regarding sensitive health information exist. Private blockchains, conversely, are permissioned networks offering enhanced control over data access and security, ideal for managing electronic health records, streamlining claims processing, and facilitating secure data sharing among healthcare providers, although they may lack the transparency of public blockchains. Hybrid blockchains combine aspects of both, providing a balance between transparency, security, and control, making them adaptable for applications like managing clinical trials, securely sharing patient data with researchers, and tracking medical devices. While private blockchains currently dominate the market due to the sensitive nature of healthcare data and the need for stringent control, public and hybrid blockchain adoption is expected to grow as healthcare organizations explore diverse applications and use cases while navigating the complexities of privacy, security, and regulatory compliance. The choice of blockchain type hinges on the specific healthcare application and organizational needs, with public blockchains suited for applications demanding high transparency, private blockchains for those involving sensitive patient data, and hybrid blockchains offering a flexible middle ground.
The North American blockchain in healthcare market is segmented by provider into technology providers, healthcare providers, and pharmaceutical companies. Technology providers are companies that develop and offer blockchain platforms, solutions, and services to the healthcare industry. These providers possess the technical expertise to build and deploy blockchain applications, catering to the specific needs of healthcare organizations. Healthcare providers, including hospitals, clinics, and physician practices, are increasingly adopting blockchain technology to improve various aspects of their operations, such as data management, supply chain tracking, and patient engagement. These providers are both consumers and potential developers of blockchain solutions, leveraging the technology to enhance their services and improve patient care. Pharmaceutical companies are utilizing blockchain to enhance supply chain transparency, combat counterfeit drugs, and improve the efficiency of clinical trials. These companies are particularly interested in leveraging blockchain to ensure the integrity of their products and maintain patient safety. The interaction between these three provider segments is crucial for the growth of the market. Technology providers offer the necessary tools and expertise, healthcare providers identify the needs and use cases, and pharmaceutical companies contribute to the development and adoption of blockchain solutions within their specific domain. Collaborations and partnerships between these segments are becoming increasingly common, fostering innovation and accelerating market growth. For instance, technology providers often partner with healthcare providers to develop customized blockchain solutions tailored to their specific requirements. Similarly, pharmaceutical companies are collaborating with technology providers to implement blockchain-based supply chain tracking systems.
The North American blockchain in healthcare market is segmented by application into supply chain management, clinical data exchange and interoperability, claims adjudication and billing, and clinical trials. Supply chain management utilizes blockchain to track pharmaceuticals and medical devices from manufacturing to distribution, ensuring product integrity and combating counterfeiting. This application is crucial for maintaining patient safety and preventing the introduction of substandard or fake medications into the market. Clinical data exchange and interoperability leverage blockchain to facilitate secure and seamless sharing of patient medical records between healthcare providers, improving care coordination and patient outcomes. This application addresses the challenge of data silos and enables healthcare professionals to access comprehensive patient information, leading to more informed treatment decisions. Claims adjudication and billing utilize blockchain to automate and streamline the claims processing process, reducing administrative costs and improving efficiency. This application can also help to prevent fraud and abuse in the healthcare insurance system. Clinical trials leverage blockchain to enhance data integrity, improve patient recruitment, and streamline regulatory compliance. This application can accelerate the drug development process and reduce the cost of bringing new medications to market. These four applications represent key areas where blockchain can significantly impact the healthcare industry, improving efficiency, security, and patient care. The adoption of blockchain in these applications is driven by the need to address existing challenges and improve processes. For example, the increasing prevalence of counterfeit drugs is driving the adoption of blockchain in supply chain management. The need for seamless data sharing between healthcare providers is driving the adoption of blockchain in clinical data exchange.
The North American blockchain in healthcare market is segmented by end user into hospitals and clinics, pharmaceutical companies, research institutions, and payers. Hospitals and clinics are adopting blockchain to improve data management, streamline administrative processes, and enhance patient care. These healthcare providers are leveraging blockchain to secure patient medical records, facilitate data exchange with other providers, and improve supply chain tracking. Pharmaceutical companies are utilizing blockchain to enhance supply chain transparency, combat counterfeit drugs, and improve the efficiency of clinical trials. These companies are focused on leveraging blockchain to ensure the integrity of their products and maintain patient safety. Research institutions are exploring the use of blockchain for various research applications, such as data sharing, patient recruitment, and clinical trial management. These institutions are leveraging blockchain to improve the efficiency and security of research processes. Payers, including insurance companies and government agencies, are utilizing blockchain to streamline claims processing, reduce fraud, and improve data management. These organizations are focused on leveraging blockchain to reduce administrative costs and improve the efficiency of healthcare transactions. The adoption of blockchain by these different end-user segments is driven by their specific needs and challenges. Hospitals and clinics are focused on improving patient care and operational efficiency. Pharmaceutical companies are focused on ensuring product integrity and patient safety. Research institutions are focused on improving the efficiency and security of research processes. Payers are focused on reducing costs and improving the efficiency of healthcare transactions. The collaboration and interaction between these end-user segments are crucial for the growth of the market. For example, hospitals and clinics may partner with pharmaceutical companies to implement blockchain-based supply chain tracking systems. Research institutions may collaborate with payers to develop blockchain solutions for clinical trial management.
The North American blockchain in healthcare market is segmented by organization size into large enterprises and small and medium-sized enterprises (SMEs). Large enterprises, including large hospital systems, pharmaceutical companies, and insurance providers, have the resources and infrastructure to implement complex blockchain solutions. These organizations are often early adopters of blockchain technology and are driving innovation in the market. SMEs, including smaller clinics, physician practices, and startups, are increasingly adopting blockchain solutions to improve efficiency and competitiveness. Cloud-based blockchain platforms and pre-built solutions are making it easier for SMEs to access and implement blockchain technology. The adoption of blockchain by both large enterprises and SMEs is crucial for the growth of the market. Large enterprises are driving innovation and setting industry standards, while SMEs are contributing to broader market adoption. The different needs and challenges of large enterprises and SMEs are shaping the development of blockchain solutions. Large enterprises often require customized solutions tailored to their specific requirements, while SMEs may prefer pre-built solutions that are easier to implement and manage. The availability of cloud-based blockchain platforms and cost-effective solutions is making

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Ask an Expert

Anuj Mulhar

Industry Research Associate

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now